| Literature DB >> 23936414 |
Rémy Saunier1, Michela Esposito, Emmanuel P Dassa, Agnès Delahodde.
Abstract
Decline of proteasome activity has been reported in mammals, flies and yeasts during aging. In the yeast Saccharomyces cerevisiae, the reduction of proteolysis in stationary phase is correlated with disassembly of the 26S proteasomes into their 20S and 19S subcomplexes. However a recent report showed that upon entry into the stationary phase, proteasome subunits massively re-localize from the nucleus into mobile cytoplasmic structures called proteasome storage granules (PSGs). Whether proteasome subunits in PSG are assembled into active complexes remains an open question that we addressed in the present study. We showed that a particular mutant of the RPN11 gene (rpn11-m1), encoding a proteasome lid subunit already known to exhibit proteasome assembly/stability defect in vitro, is unable to form PSGs and displays a reduced viability in stationary phase. Full restoration of long-term survival and PSG formation in rpn11-m1 cells can be achieved by the expression in trans of the last 45 amino acids of the C-terminal domain of Rpn11, which was moreover found to co-localize with PSGs. In addition, another rpn11 mutant leading to seven amino acids change in the Rpn11 C-terminal domain, which exhibits assembled-26S proteasomes, is able to form PSGs but with a delay compared to the wild type situation. Altogether, our findings indicate that PSGs are formed of fully assembled 26S proteasomes and suggest a critical role for the Rpn11 protein in this process.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23936414 PMCID: PMC3735599 DOI: 10.1371/journal.pone.0070357
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Phenotypes of the rpn11-m1 and rpn11-m5 mutant strains.
(A) Alignment of the carboxyl amino acid sequences of Rpn11, Rpn11-m1 and Rpn11-m5. The amino acid changes are in orange. (B) Wild type (W303-1B background), rpn11-m1 and rpn11-m5 cells expressing mtGFP were grown to log phase in glucose containing medium (YPD) and examined by fluorescence (right) and phase contrast (left) microscopy. (C) Cell extracts prepared from exponentially growing wild type, rpn11-m1 or rpn11-m5 strains, brought to an identical cell density at the permissive temperature of 26°C were clarified by centrifugation, and samples containing identical amounts of total protein were separated by non-denaturing PAGE (native gels). Proteasomes were visualized by the fluorogenic peptide overlay assay. Proteasome holoenzymes in WT and rpn11-m5 are found as a mixture of symmetric doubly capped (RP2CP) and asymmetric singly capped (RP1CP) conformations. 26S proteasomes in rpn11-m1 are found almost exclusively in lidless forms (B2-CP or B1-CP). 20S CP is visualized upon activation of the CP by 0.05% SDS (right panel). Higher levels of dissociated free 20S CP are evident in rpn11-m1 and more discrete for rpn11-m5. (D) Survival during starvation-induced stationary phase of wild type, rpn11-m1 and rpn11-m5 strains on glucose containing rich medium (YPD) at 26°C after growth for 1, 21 and 42 days. Comparable number of cells was spotted at 10-fold dilutions on YPD medium.
Figure 2Proteasome subunits localization in exponential and stationary growth phases.
Wild type, rpn11-m1 and rpn11-m5 cells expressing Rpn5-GFP (W303), Rpn1-GFP (W303) or Pre6-GFP (BY4741) were grown in glucose and adenine containing rich medium (YPDA) at 26°C and examined by fluorescence microscopy in the exponential growth phase (EP) and after 5 days in stationary phase (SP). Typical images of each subunit fused to GFP localization are shown. (CP/20S Core Particle).
Figure 3Rpn5-GFP localization in proteasome assembly defect mutant cells in exponential and stationary growth phases.
Wild type, Δump1, Δrpn10 and Δspg5 cells expressing Rpn5-GFP were grown in glucose containing rich medium (YPD) at 26°C and examined by fluorescence microscopy in the exponential growth phase (EP) and after 5 days in stationary phase (SP). Typical images of Rpn5-GFP localization are shown.
Figure 4Localization of Rpn5-GFP in proteasome mutants defective in 26S assembly/stability.
(A) Wild type, rpn11-m1 and rpn11-m5 cells expressing Rpn5-GFP were grown in YPDA medium at 26°C during 8 days. For each time point (day), the OD600 nm was monitored, the survival rate performed (Figure S1) and the localization of Rpn5-GFP fluorescence was scored as nuclear (blue bar), at the nuclear periphery (red bar) or as cytosolic dots (green bar; n>100 cells for each time point; two independent experiments; error bars report the differences between the two experiments). (*) indicate that the differences in the distribution of the Rpn5-GFP signal in the mutant cells are significant relative to the wild-type cells after statistical analyses (Pearson’s chi-squared test, P values <0.05). (B) Wild type and rpn11-m5 cells producing Rpn5-GFP were grown in YPDA medium at 26°C during 7 days. Localization of Rpn5-GFP was scored as in (A) but every day from day 1 to day 5 and at day 7. (C) Comparison of Rpn5-GFP-cytosolic foci apparition between the wild type (grey) and the rpn11-m5 mutant (black) for each day. Error bars represent the difference observed between the two experiments and (*) indicates that the difference between the two strains is significant (Fisher’s exact test, P values <0.05).
Figure 5Actin cytoskeleton organization upon entry into the stationary phase.
Wild type, rpn11-m1 and rpn11-m5 cells were grown in YPDA medium at 26°C. At various stage (A) exponential phase, (B) diauxic shift and (C) after five days in stationary phase, cells were taken off and stained with Alexa-phalloidin.
Figure 6Overexpression of the Rpn11 carboxyl terminus.
(A) Survival during starvation-induced stationary phase of wild type or rpn11-m1 strains containing the plasmid overexpressing the 45 amino acids of the Rpn11 carboxyl terminus (C-R11(45)) or its mutated form (C-R11m1(25)) on rich medium (YPD) at 26°C after growth for 1 and 15 days in rich medium at 26°C. Comparable number of cells was spotted at 10-fold dilutions on YPD medium. (B) Wild type and rpn11-m1 cells expressing Rpn1-GFP and overproducing C-R11(45) or C-R11m1(25) were grown in rich medium (YPDA) at 26°C and examined by fluorescence microscopy in the exponential growth phase (EP) and after 5 days in stationary phase (SP). Typical images of Rpn1-GFP localization are shown. (C) Wild type and rpn11-m1 cells expressing Rpn1-GFP and overproducing C-R11(45) or C-R11m1(25) were grown in YPDA medium at 26°C. For each time point (day), the localization of Rpn1-GFP fluorescence was scored as nuclear (blue bar), at the nuclear periphery (red bar) or as cytosolic dots (green bar; n>100 cells for each time point; two independent experiments; error bars report the differences between the two experiments) and (*) indicate that the difference in the distribution of the Rpn1-GFP signal in the mutant cells are significant relative to the wild-type cells both overproducing C-R11(45) after statistical analyses (Pearson’s chi-squared test, P values <0.05). (D) Comparison of Rpn1-GFP-cytosolic foci apparition between the wild type (grey) and the rpn11-m5 mutant (black) both overexpressing C-R11(45) for each day. Error bars represent the difference observed between the two experiments and (*) indicates that the difference between the two strains is significant (Fisher’s exact test, P values <0.05).
Figure 7Co-localization of Rpn5-GFP and the mCherry fused to C-R11(45) or C-R11m1(25) in rpn11-m1 cells.
Wild type and rpn11-m1 cells co-expressing Rpn5-GFP and the mCherry fused to the Rpn11 carboxyl terminus domain (mCherry-C-R11(45)) or to its mutated form (mCherry-CR11m1(25)) were grown in YPDA medium at 26°C and examined by fluorescence microscopy. Typical co-localization images obtained after one day of culture (exponential phase, EP) or after five days in stationary phase (SP). The white arrow in the last image points to a PSG, which is enlarged in the same image.
Strains used in this study.
| Strain name | Genotype | Source |
|
|
|
|
|
|
|
|
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| Invitrogen |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| Invitrogen |
|
|
| Invitrogen |
|
|
| Invitrogen |